“Sustained Complete Response to a Short Course of Subcutaneous Daratumumab in Multi-Refractory Immune Thrombocytopenia”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 18, no. 1, Sept. 2026, p. e2026069, https://doi.org/10.4084/MJHID.2026.069.